AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news

Teva

20 stories about Teva
מנכ"ל טבע החדש קור שולץ 1

Teva to Unveil Strategic Plan, Layoffs Thursday

12.12.17|Dror Reich
Last month the debt-riddled drug maker announced a rehabilitation plan amidst rumors of upcoming employee cuts
ההכרזה של דולנד טראמפ על ירושלים 2

CTech’s Daily Israeli Tech News Roundup

10.12.17|CTech
Backlash against Trump’s Jerusalem declaration has reached Israeli tech. AmTrust is planning a listing on Tel Aviv Stock Exchange. Teva’s stock is up following news of more layoffs.
מפעל טבע נתניה

Teva’s Stock Jumps Following Report on Planned Cuts

10.12.17|Dror Reich and Lilach Baumer
On Friday, Bloomberg reported that Teva might be slashing as many as 10,000 jobs, citing sources. Last month, Calcalist reported Teva is planning to cut over 4,000 jobs in the U.S. and Israel
לוגו ctech

CTech’s Weekly Israeli Tech News Roundup

01.12.17|CTech
Amazon’s plans to open local distribution center, Uber’s retreated after facing legal pressure, and Teva is going back to its roots
לוגו ctech

CTech’s Daily Israeli Tech News Roundup

30.11.17|CTech
VC firm NFX wants to change the world (or at least the VC industry), Teva’s troubles just don’t seem to end (this time it’s a potential derivative action lawsuit) and Deloitte publishes its Israel Technology Fast 50 list, which has old industry veterans and some newcomers
חברת ה תרופות טבע Teva

Fresh Teva Lawsuit Goes Against Dividends Paid by Debt Heavy Drugmaker

30.11.17|Anat Rouah
Tel Aviv-based capital investment firm Tulip Capital is threatening derivative action against Teva, saying the company's huge debt load renders its dividends unlawful
לוגו ctech

CTech’s Daily Israeli Tech News Roundup

28.11.17|CTech
The arrest of a man who promoted “risk-free” investments in startups, Teva’s strategy for recovery, and Turkish search engine used by authorities to suppress free speech
מנכ"ל טבע החדש קור שולץ

New CEO Steers Teva Back to Generics

28.11.17|Golan Hazani and Dror Reich
A reorganization plan announced by the company Monday would see the troubled drugmaker return to its core competencies, despite market pressures
מנכ"ל טבע החדש קור שולץ 2

Teva Announces Restructuring, Ousts Second in Command

27.11.17|Golan Hazani
The troubled Israeli drugmaker has combined its generic and specialty drug divisions, effective immediately
לוגו ctech

CTech’s Daily Israeli Tech News Roundup

26.11.17|CTech
Amazon plans to set up a shipping center in Israel. Israeli parliamentarian criticizes Israeli arms export policy.
מפעל טבע הר חוצבים ירושלים

Mylan's Chairman was Right

26.11.17|Sophie Shulman
In a 2015 letter, Robert J. Coury forecasted Teva’s current troubles
מנכ"ל טבע החדש קור שולץ 2

Israeli Parliamentarians to Push Against Teva Layoffs in the Country

26.11.17|Dror Reich and Maayan Manela
Shelly Yachimovich, a member of the Israeli parliament representing the Israeli Labor Party, said she intends to call an emergency hearing of the Israeli parliament’s state control committee on the issue. The planned layoffs are a result of the company’s management failures, she added
לוגו ctech

CTech's Weekly Israeli Tech News Roundup

24.11.17|CTech
Teva to axe over 4,000 employees. Hedge fund warns it may push to replace board at chip company Mellanox. Big Tech bails on Israeli Treasury party
לוגו ctech

CTech’s Daily Israeli Tech News Roundup

23.11.17|CTech
Teva’s troubles lead to more employee cuts and Periggo completes the sale of its business unit in Israel, but Dutch cannabis is joining the kibbutz. Also, Israel’s private eyes say Black Cube broke the rules.
מנכ"ל טבע החדש קור שולץ 2

Troubled Drugmaker Teva to Axe over 4,000 Jobs

23.11.17|Golan Hazani
Less than a month after stepping in as CEO, Kåre Schultz starts tightening the belt. The company is expected to oust Chief Scientific Officer Michael Hayden
default image

Allergan to Sell Teva Shares to J.P. Morgan

14.11.17|Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
אננס אננסים

MediWound Loses Stock Purchase Agreement Case

14.11.17|Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
מדענית ב מעבדת אבטחת איכות של חברת טבע TEVA

JPMorgan Downgrades Teva’s Stock to Underweight

13.11.17|Amarelle Wenkert
Christopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit
default image

Generic Focus made Kite Pharma Founder Leave Teva

13.11.17|Dror Reich
Founder of cancer treatment company sold to Gilead Sciences for $12 billion, says Gilead wants “to crack the cancer market"
ראג'יב מאליק נשיא מיילן

Investors Cheer as Mylan Plans to Delist from Israeli Stock Exchange

12.11.17|Uri Tal-Tenne and Dror Reich
Mylan is currently the highest valued company on the TASE at $18.5 billion
Previous ArticlesMore Articles